Heart Failure With Reduced Ejection Fraction Clinical Trials Database - Free Access to 62 Studies
Access comprehensive clinical trial information for Heart Failure With Reduced Ejection Fraction through Pure Global AI's free database. This collection includes 62 clinical trials across multiple phases including N/A, Phase 4, Phase 2. Currently, 23 trials are actively recruiting participants.
Research for Heart Failure With Reduced Ejection Fraction is being conducted in United States of America, Denmark, Egypt and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Duke University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC
Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients
Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure
EHR Nudges to Improve Quality of Care in HF
Effects of 2-week Ketosis on the Heart's Ketone Body Consumption, Utilization, and Energetic Efficiency in Patients With Chronic Heart Failure
Exploration of Clonal Hematopoiesis of Indeterminate Potential in Non-ischemic Heart Failure With Reduced Ejection Fraction
Initiation of ARNi and SGLT2i in Patients With HFrEF
A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure
Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure
Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
The Anti-myocardial Fibrosis Effect of Vericiguat in HFrEF
Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction
Ketone Pharmacokinetic Study in HFrEF
Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells
A Virtual Heart Failure Optimization Program for Guideline Directed Medical Therapy and Cardiac Rehabilitation
Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction
The Effect of Uncertainty in Heart Failure
Phase Ib/IIa Trial With AC01 in Patients With HFrEF
PHARM Optimal-HF Pilot
Pure Global AI provides free access to 62 clinical trials studying Heart Failure With Reduced Ejection Fraction, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Novartis Pharmaceuticals, Duke University, Cytokinetics, among others.